Detail

Keywords

Biological Therapy; Brain Neoplasms; Medical Oncology; Neoplasm Metastasis; Neurooncology; Prognosis

Research group(s)

• Brain Tumor Program
  Members:
  Matthias Preusser
  Maximilian Mair
• Immuno-oncology program
  Members:
  Matthias Preusser
  Maximilian Mair

Selected publications

1. Berghoff, A.S. et al., 2014. Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma. Neuro-Oncology, 17(8), pp.1064-1075. Available at: http://dx.doi.org/10.1093/neuonc/nou307.
2. Preusser, M. et al., 2015. Spectrum of gene mutations detected by next generation exome sequencing in brain metastases of lung adenocarcinoma. European Journal of Cancer, 51(13), pp.1803-1811. Available at: http://dx.doi.org/10.1016/j.ejca.2015.06.107.
3. Goldbrunner, R. et al., 2016. EANO guidelines for the diagnosis and treatment of meningiomas. The Lancet Oncology, 17(9), pp.e383-e391. Available at: http://dx.doi.org/10.1016/S1470-2045(16)30321-7.
4. Preusser, M. et al., 2015. Prospects of immune checkpoint modulators in the treatment of glioblastoma. Nature Reviews Neurology, 11(9), pp.504-514. Available at: http://dx.doi.org/10.1038/nrneurol.2015.139.
5. Osswald, M. et al., 2015. Brain tumour cells interconnect to a functional and resistant network. Nature. Available at: http://dx.doi.org/10.1038/nature16071.